🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
ME Therapeutics Holdings Inc. (CSE:METX)
Canada flag Canada · Delayed Price · Currency is CAD
1.050
0.00 (0.00%)
Nov 19, 2026, 9:30 AM EST

ME Therapeutics Holdings Income Statement

Millions CAD. Fiscal year is Sep - Aug.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
May '26 Aug '25 Aug '24 Aug '23 Aug '22
Selling, General & Admin
0.710.610.370.360.08
Research & Development
0.730.410.310.030.05
Operating Expenses
1.551.281.370.980.15
Operating Income
-1.55-1.28-1.37-0.98-0.15
Interest Expense
-0.01-0.01--0.01-0.01
Interest & Investment Income
0.020.040.030.01-
Other Non Operating Income (Expenses)
0.160.060.05-0.02
EBT Excluding Unusual Items
-1.38-1.19-1.29-0.97-0.15
Other Unusual Items
----5.55-
Pretax Income
-1.38-1.19-1.29-6.52-0.15
Net Income
-1.38-1.19-1.29-6.52-0.15
Net Income to Common
-1.38-1.19-1.29-6.52-0.15
Net Income Growth
-----
Shares Outstanding (Basic)
302824168
Shares Outstanding (Diluted)
302824168
Shares Change
11.85%14.17%55.90%84.08%-
EPS (Basic)
-0.05-0.04-0.05-0.42-0.02
EPS (Diluted)
-0.05-0.04-0.05-0.42-0.02
EPS Growth
-----

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
May '26 Aug '25 Aug '24 Aug '23 Aug '22
Free Cash Flow
-1.29-1.08-0.66-0.3-0.14
Free Cash Flow Per Share
-0.04-0.04-0.03-0.02-0.02
EBITDA
-1.54-1.24-1.37-0.98-0.15
D&A For EBITDA
0.010.03000
EBIT
-1.55-1.28-1.37-0.98-0.15